Four Decades of Randomized Clinical Trials Influencing Mortality in Critically Ill and Perioperative Patients
URL: https://www.jcvaonline.com/article/S1053-0770(22)00227-0/fulltext
DOI: 10.1053/j.jvca.2022.04.022
Published online:Journal of Cardiothoracic and Vascular Anesthesia, April 07, 2022
Authors: Romero CS, Romero E, Maimieri N, Popp M, Marchetti C, Lombardi G, Ortalda A, Zangrillo A, Landoni G.
Article description
Summary:
- Randomized clinical trials (RCTs) is taken as the highest level of scientific evidence
- A review of RCTs published between January 1982 and January 2021 was performed
- With the aim of mapping and summarizing the main characteristics and publication trends of RCTs with a statistically significant effect on mortality in critically ill and perioperative patients
- A descriptive analysis was conducted, including general and methodologic information of all these RCTs with a statistically significant difference (p < 0.05) in mortality
- 340 studies published in 115 journals from 42 countries were identified
- Ventilatory support (n = 58, 17%) and hemodynamics (n = 56, 16%), were represented the most
- 47 (14%) RCTs described a detrimental effect on survival
- Denmark published the highest number of trials per million population
- Female authors led 12% of RCT
- Publishing in a high impact factor journal increased the application of the intention-to-treat principle in RCTs from 60% to 75%
Conclusions:
- An increase in scientific production of RCTs studying, interventions that significantly influences mortality, was found
- The main contributors of RCTs in the field during this period were the United States, China, France, Italy, and the United Kingdom, with 172 (51%)
- 20% of studies were multinational collaborations
- 1 in 8 RCT’s was authored by a female